Serotonin transporter polymorphism in Croatian patients with major depressive disorder
- PMID: 16804504
Serotonin transporter polymorphism in Croatian patients with major depressive disorder
Abstract
Objectives: Differences in serotonin transporter (SERT) expression and function produced by gene polymorphisms are associated with several behavioral and psychiatric traits. Two polymorphic regions of SERT gene: a 44-base-pair (bp) insertion / deletion polymorphism in the promoter region (SERTPR), and variable number of tandem repeats (VNTR) in second intron (SERT-in2) have been characterized. In this study we investigated the frequency distribution of polymorphic variants of short (S, s) and long (L, l) alleles, genotypes and haplotypes of SERTPR, and SERTin2, in patients with major depressive disorder (MDD) and compared it with results obtained from the Croatian healthy population.
Subjects and methods: one hundred and fourteen patients who fulfilled DSM-IV criteria for a diagnosis of MDD were included in the study. Comparisons were made with the results obtained for 120 healthy volunteers representing a mixed Croatian population. SERT genotyping was performed by the PCR (polymerase-chain reaction) method.
Results: The frequency distribution of L and S alleles and genotypes of SERTPR was not statistically different between MDD patients and control participants. The proportion of SERT-in2 short (s) alleles was significantly higher among MDD patients in comparison to healthy subjects (p = 0.04).
Conclusion: "s" allele variant in the intron 2 of SERT gene could be associated with susceptibility to MDD.
Similar articles
-
Increased risk for major depression associated with the short allele of the serotonin transporter promoter region (5-HTTLPR-S) and the CYP2C9*3 allele.Fundam Clin Pharmacol. 2007 Aug;21(4):451-3. doi: 10.1111/j.1472-8206.2007.00501.x. Fundam Clin Pharmacol. 2007. PMID: 17635185
-
[Association of neurocognitive endophenotype and STin2 polymorphism in major depressive disorder].Neuropsychopharmacol Hung. 2007 Jun;9(2):53-62. Neuropsychopharmacol Hung. 2007. PMID: 17970527 Hungarian.
-
[Association study of sleep apnea syndrome and polymorphisms in the serotonin transporter gene].Zhonghua Yi Xue Yi Chuan Xue Za Zhi. 2005 Oct;22(5):533-6. Zhonghua Yi Xue Yi Chuan Xue Za Zhi. 2005. PMID: 16215942 Chinese.
-
5-hydroxytryptamine in the cardiovascular system: focus on the serotonin transporter (SERT).Clin Exp Pharmacol Physiol. 2006 Jul;33(7):575-83. doi: 10.1111/j.1440-1681.2006.04410.x. Clin Exp Pharmacol Physiol. 2006. PMID: 16789923 Review.
-
Serotonin transporter polymorphism in major depressive disorder (MDD), psychiatric disorders, and in MDD in response to stressful life events: causes and treatment with antidepressant.In Vivo. 2011 Nov-Dec;25(6):895-901. In Vivo. 2011. PMID: 22021682 Review.
Cited by
-
Association of polymorphic variants in serotonin re-uptake transporter gene with Crohn's disease: a retrospective case-control study.Croat Med J. 2018 Oct 31;59(5):232-243. doi: 10.3325/cmj.2018.59.232. Croat Med J. 2018. PMID: 30394015 Free PMC article.
-
Genetic contributions of the serotonin transporter to social learning of fear and economic decision making.Soc Cogn Affect Neurosci. 2009 Dec;4(4):399-408. doi: 10.1093/scan/nsp019. Epub 2009 Jun 17. Soc Cogn Affect Neurosci. 2009. PMID: 19535614 Free PMC article.
-
Long acting aripiprazole influences cognitive functions in recent onset schizophrenia.Psychopharmacology (Berl). 2021 Jun;238(6):1563-1573. doi: 10.1007/s00213-021-05788-w. Epub 2021 Feb 13. Psychopharmacology (Berl). 2021. PMID: 33580813
-
Serotonin transporter gene polymorphism and psychiatric disorders: is there a link?Indian J Psychiatry. 2011 Oct;53(4):289-99. doi: 10.4103/0019-5545.91901. Indian J Psychiatry. 2011. PMID: 22303036 Free PMC article.
-
Serotonin transporter polymorphism (5-HTTLPR) in Croatian population.Mol Biol Rep. 2015 Feb;42(2):553-8. doi: 10.1007/s11033-014-3800-7. Epub 2014 Nov 6. Mol Biol Rep. 2015. PMID: 25374429